“EVALUATION OF THE ROLE OF FECAL CALPROTECTIN AS A BIOMARKER OF ENDOSCOPIC DISEASE ACTIVITY IN PATIENTS WITH CROHN’S DISEASE ”, Glob. j. public health med., vol. 8, no. 1 (Ongoing), pp. 216–227, Sep. 2026, doi: 10.37557/33f44713.